EPCA-2 update number 4

Dr. Diamandis has published an opinion about EPCA2 at: http://www.clinchem.org/cgi/reprint/clinchem.2009.140061v1 Since a subscription is required, here is the gist of Dr. Diamandis’s contribution. First, he mentions that Dr. Getzenberg has published a new article about EPCA-2 (1) (subscription also required). In the Getzenberg article, Dr. Diamandis says that the claim has been dropped by Dr. Getzenberg that EPCA-2 distinguishes between organ confined and non organ confined prostate cancer. Otherwise, the Prostate article validates Getzenberg’s other previous claims about the EPCA-2 marker. The abstract is at: http://www3.interscience.wiley.com/journal/122373646/abstract?CRETRY=1&SRETRY=0

Dr. Diamandis’s Clinical Chemistry article says that according to ELISA assay principles and now demonstrated experimentally, the Getzenberg assay was incapable of measuring EPCA-2 at the levels claimed and thus, the results had could only be explained by some sort of bias.

So the story continues.


  1. Leman ES, Magheli A, Canon GW, Mangold L, Partin AW, Getzenberg RH. Analysis of a serum test for prostate cancer that detects a second epitope of EPCA-2. Prostate 2009;69:1188 –94.

One Response to EPCA-2 update number 4

  1. […] was that there were likely problems with the EPCA-2 assay. But this is not news as it was already reported by Dr. Diamandis. So not much to […]

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: